340 research outputs found

    Growth, yield and nutrient uptake of hybrid rice as influenced by nutrient management modules and its impact on economic of the treatments

    Get PDF
    Field experiment was conducted at Instructional Farm of Narendra Deva University of Agriculture and Technology, Kumarganj, Faizabad to develop nutrient management modules for efficient cultivation of hybrid rice. Results showed that growth and yield characters viz. plant height, number of tilers and panicles per hills were high-est under nutrient management module of 100% NPK + 5 t press mud (T3). Significantly higher grain and straw yield was recorded under treatment T3 over all the treatment except treatment T1, T2, T4, T5 and T6 which were recorded on par. Uptake of NPKS and Zn was significantly improved under treatments having organic manure along with inorganic levels (100%, 75% and 50% NPK) of fertilizer over alone levels of inorganic fertilizer. NPKS and Zn uptake was higher in treatment module T3 followed by treatment T2 (100% NPK + 10 t FYM ha-1). The net return Rs. 27373.70 ha-1 and 26087.0 ha-1 and benefit: cost ratio (1.53 and 1.45) was maximum in treatment T3 closely followed by T2. Findings of this study warranted that treatment module T3 resulted higher growth and yield of rice crop. Net return was also higher in this treatment

    Prevalence of ocular morbidity in rural population of eastern Uttar Pradesh, India

    Get PDF
    Background: Ocular morbidity is a significant problem in rural areas of India as it remains undiagnosed and neglected. Aims & Objectives:  To determine the prevalence of ocular morbidity in the rural population of Barabanki, Uttar Pradesh. Material & Methods: A community based cross-sectional study was conducted in the villages around RHTC Satrikh of HIMS Barabanki. Ocular examination and vision testing was done among 812 people using ophthalmoscopic instruments. Information was collected using pre-tested questionnaire. Analysis was done using SPSS and appropriate Statistical tests. Results: Of the total 812 individuals interviewed, the prevalence of ocular morbidity was 41.3% (335 subjects had one or more ocular morbidity); with 88.8% elderly affected (age >65 years).   Myopia was the most common ocular morbidity 14.8%, followed by cataract (14.3%) and hypermetropia (12.8%).  Allergic and infective conjunctivitis affected 5.8% and 3.9%, respectively.  The prevalence of Vitamin A deficiency disorder (including night blindness and bitot spots) was 1.3%.  Higher ocular morbidity was present in houses with higher SES. Environmental conditions had no significant relation to ocular morbidity.  Conclusion: The prevalence of ocular diseases among the elderly was highest and requires prompt attention.  Myopia was the most common ocular morbidity having a prevalence of 14.8%, followed by cataract (14.3%) and hypermetropia (12.8%)

    Farmakokinetika cefotaksima u bivolske teladi nakon višekratne primjene.

    Get PDF
    The pharmacokinetic pattern of cefotaxime following its repeated dosing was studied in buffalo calves. Cefotaxime was given at a dose rate of 13 mg/kg, first by intravenous route (i.v.) followed by intramuscular (i.m.) administration, 8 hourly for 5 days. Plasma levels of cefotaxime equivalent at different pre-determined time intervals were estimated. At 1 min, after first i.v. injection, plasma level was 71.7 ± 6.01 μg.ml-1, which gradually declined and drug was detected up to 8 h (0.09 ± 0.05 μg.ml-1). Plasma concentration of cefotaxime equivalent at 15, 20, 30 and 480 min following all repetitions was almost the same. After final intramuscular injection, peak plasma concentration (11.0 ± 0.24 μg.ml-1) was detected at 20 min, which declined to 0.08 ± 0.04 μg.ml-1 at 8 h. On comparing the data on plasma levels of repeated intramuscular injections with first intravenous injection, it was revealed that repeated intramuscular injections of cefotaxime have no prolonged therapeutic effect and lack any cumulative effect. Perusal of kinetic determinants of cefotaxime following first i.v. injection and last i.m. injection revealed no significant difference in relation to β, t1/2β, AUC, Vd(area) and ClB. Such lack of variation indicated that repeated administration of cefotaxime did not alter its disposition kinetics.Istražene su farmakokinetičke osobine cefotaksima u bivolske teladi nakon njegove višekratne primjene. Cefotaksim je bio dan u dozi od 13 mg/kg t.m. prvi puta intravenski (i.v.), a potom intramuskularno (i.m.) s razmacima od 8 sati i to tijekom 5 uzastopnih dana. U pokusu je određivana koncentracija cefotaksima u krvnoj plazmi u različitim, prethodno određenim, vremenskim razmacima. Jednu minutu nakon i.v. injekcije razina cefotaksima u plazmi bila je 71.7 ± 6.01 mg/ml te se postupno smanjivala, a niske koncentracije ovog cefalosporina utvrđene su sve do 8 sati nakon davanja (0.09 ± 0.05 mg/ml). Razine cefotaksima u plazmi bile su nepromijenjene 15, 20, 30 i 480 minuta nakon opetovanog davanja. Po posljednjoj i.m. injekciji vršna razina u plazmi utvrđena je nakon 20 minuta (11.0 ± 0.24 mg/ml), a po isteku 8 sati iznosila je 0.08 ± 0.04 mg/ml. Usporedbom vrijednosti koncentracije cefotaksima u plazmi nakon ponovljene i.m. primjene, s koncentracijama poslije prvog i.v. davanja, moglo se utvrditi da opetovane i.m. injekcije cefotaksima ne produžuju njegov terapijski učinak, tj. da se ovaj antibiotik ne kumulira u organizmu. Pažljivim promatranjem kinetičkih pokazatelja cefotaksima nakon njegove prve intravenske i posljednje intramuskularne injekcije utvrđeno je da nema signifikantnih razlika u vrijednostima kao što su: konstanta eliminacije (β), poluvrijeme eliminacije lijeka iz plazme (t1/2β), površina ispod koncentracijske krivulje lijeka u plazmi (area under the curve - AUC), prividni volumen raspodjele (Vd(area)) i ukupni klirens lijeka iz organizma (ClB). Nedostatak promjena u navedenim farmakokinetičkim pokazateljima ukazuje da višekratna primjena cefotaksima nije mijenjala kinetiku dispozicije ovog cefalosporinskog antibiotika treće generacije

    THE IMPACT OF VARIOUS INDIAN MEDICINAL PLANTS AS A WOUNDS HEALER

    Get PDF
    Many requirements of human beings are fulfilled by the plants. They also prevent and cure various diseases of human beings including wounds and ulcers. Plants and their extracts have immense potential for the management and treatment of wounds. The management of wound has been a major problem since the early stages of medical science. In spite of brilliant progress of in surgery, wound management still remains a subject of speculation. The early manifestation of unsatisfactory wound healing gives rise to serious complications which can lead to prolonged healing and even death in surgical practice. These natural medicines for wound healing are cheap, affordable and purportedly safe as hyper sensitive reactions are rarely encountered with the use of these agents. These natural agents induce healing and regeneration of the lost tissue by multiple mechanisms. However, there is a need for scientific validation, standardization and safety evaluation of plants of the traditional medicine recommended for healing of the wounds

    Synthesis and antibacterial studies on some new thiazole moiety based quinolone derivatives

    Get PDF
    1413-1415Thiazole moiety at C-3 position based quinolone derivatives have been synthesized from the starting material aniline and its derivatives. All synthesized compounds in this series have been tested for in vitro antibacterial activity against E. coli (ETEC), S. typhi, P. aeruginosa and S. aureus. All synthesized compound have been tested with reference drugs viz., norfloxacin and ciprofloxacin
    corecore